ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 239 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $149,000 | -9.7% | 2,587 | 0.0% | 0.00% | -25.0% |
| Q1 2015 | $165,000 | +3.1% | 2,587 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $160,000 | +60.0% | 2,587 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $100,000 | -71.5% | 2,587 | -74.6% | 0.00% | -75.0% |
| Q2 2014 | $351,000 | +9.3% | 10,201 | +37.3% | 0.01% | +14.3% |
| Q1 2014 | $321,000 | -30.7% | 7,432 | -36.1% | 0.01% | -30.0% |
| Q4 2013 | $463,000 | -13.1% | 11,623 | -18.1% | 0.01% | -16.7% |
| Q3 2013 | $533,000 | +225.0% | 14,193 | +132.5% | 0.01% | +200.0% |
| Q2 2013 | $164,000 | – | 6,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |